Douglas B. Johnson
- Oncology top 2%
- Cardiology and Cardiovascular Medicine top 5%
- Pulmonary and Respiratory Medicine top 10%
- Immunology
- Molecular Biology
- Co-authors
- Joe‐Elie SalemJavid J. MoslehiBénédicte Lebrun‐VignesMarc P. BonacaMelissa MoeyJean‐Philippe SpanoAli ManouchehriJustin M. Balko
- Topics
- Cancer Immunotherapy and Biomarkers (9 papers)CAR-T cell therapy research (4 papers)Immune Cell Function and Interaction (3 papers)
- Partner nations
- United StatesFranceCanada
In The Last Decade
Douglas B. Johnson
10 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 73
- Oncology 1.1k
- Cardiology and Cardiovascular Medicine 536
- Pulmonary and Respiratory Medicine 235
- Immunology 198
- Molecular Biology 160
Countries citing papers authored by Douglas B. Johnson
This map shows the geographic impact of Douglas B. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas B. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas B. Johnson more than expected).
Fields of papers citing papers by Douglas B. Johnson
This network shows the impact of papers produced by Douglas B. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas B. Johnson. The network helps show where Douglas B. Johnson may publish in the future.
Co-authorship network of co-authors of Douglas B. Johnson
This figure shows the co-authorship network connecting the top 25 collaborators of Douglas B. Johnson. A scholar is included among the top collaborators of Douglas B. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas B. Johnson. Douglas B. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 18 | |
| 4 | 47 | |
| 5 | 80 | |
| 6 | 96 | |
| 7 | 88 | |
| 8 | 60 | |
| 9 | 288 | |
| 10 | Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance studybreakdown → | 836 |
About Douglas B. Johnson
Douglas B. Johnson is a scholar working on Transplantation, Oncology and Immunology, having authored 10 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), CAR-T cell therapy research (4 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Oncology (1.1k citations), Cardiology and Cardiovascular Medicine (536 citations) and Toxicology (34 citations). Douglas B. Johnson has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Joe‐Elie Salem, Javid J. Moslehi, Bénédicte Lebrun‐Vignes, Marc P. Bonaca, Melissa Moey, Jean‐Philippe Spano, Ali Manouchehri, Justin M. Balko, Dan M. Roden and Lisa Bastarache. Their work appears in journals such as Circulation, Circulation Research and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.